These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4831648)

  • 21. Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs.
    Vatner SF; McRitchie RJ; Maroko PR; Patrick TA; Braunwald E
    J Clin Invest; 1974 Sep; 54(3):563-75. PubMed ID: 4152859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of inotropic agents on glycerol release and protein kinase activity ratios in the isolated perfused rat heart.
    Jesmok GJ; Calvert DN; Lech JJ
    J Pharmacol Exp Ther; 1977 Jan; 200(1):187-94. PubMed ID: 833756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenergic control of myocardial contractility in conscious hyperthyroid dogs.
    Rutherford JD; Vatner SF; Braunwald E
    Am J Physiol; 1979 Nov; 237(5):H590-6. PubMed ID: 495765
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistence of contractile behaviour in acutely ischaemic myocardium.
    Hood WB; Covelli VH; Abelmann WH; Norman JC
    Cardiovasc Res; 1969 Jul; 3(3):249-60. PubMed ID: 5822484
    [No Abstract]   [Full Text] [Related]  

  • 25. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of some effects of glucagon and isoprenaline on the cardiovascular system of the anaesthetized dog.
    Shanks RG; Zaidi SA
    Br J Anaesth; 1972 May; 44(5):427-32. PubMed ID: 5044070
    [No Abstract]   [Full Text] [Related]  

  • 27. A differential inotropic responsiveness to isoprenaline and ouabain in dogs with heart failure.
    Newman WH; Webb JG
    Cardiovasc Res; 1980 Sep; 14(9):530-6. PubMed ID: 7214396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic and coronary hemodynamic effects of glucagon.
    Rowe GG
    Am J Cardiol; 1970 Jun; 25(6):670-4. PubMed ID: 5420906
    [No Abstract]   [Full Text] [Related]  

  • 29. A polypeptide (AP-A) from sea anemone (Anthopleura xanthogrammica) with potent positive inotropic action.
    Shibata S; Norton TR; Izumi T; Matsuo T; Katsuki S
    J Pharmacol Exp Ther; 1976 Nov; 199(2):298-309. PubMed ID: 10426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
    Schuster DP; Lucchesi BR; Nobel NL; Mimnaugh MN; Counsell RE; Kniffen FJ
    J Pharmacol Exp Ther; 1973 Jan; 184(1):213-27. PubMed ID: 4405548
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacology of the coronary circulation.
    Dempsey PJ; Cooper T
    Annu Rev Pharmacol; 1972; 12():99-110. PubMed ID: 4339021
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of regional myocardial function in ischemic heart disease by echocardiography.
    Kerber RE; Marcus ML
    Prog Cardiovasc Dis; 1978; 20(6):441-50. PubMed ID: 644094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pharmacologic agents on the function of the ischemic heart.
    Maroko PR; Libby P; Braunwald E
    Am J Cardiol; 1973 Dec; 32(7):930-6. PubMed ID: 4757233
    [No Abstract]   [Full Text] [Related]  

  • 34. Stimulation of monovalent cation active transport by low concentrations of cardiac glycosides. Role of catecholamines.
    Hougen TJ; Spicer N; Smith TW
    J Clin Invest; 1981 Nov; 68(5):1207-14. PubMed ID: 7298847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of ouabain on experimental cardiac depression induced by propranolol in dogs].
    Laubie M; Drouillat M; Roblin M
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):183-91. PubMed ID: 4943207
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparative description of inotropic agents in vitro.
    Spilker BA
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):325-41. PubMed ID: 4694369
    [No Abstract]   [Full Text] [Related]  

  • 37. Regulation of cardiac output after administration of isoproterenol and ouabain: interactions of systolic impedance and contractility.
    Liedtke AJ; Buoncristiani JF; Kirk ES; Sonnenblick EH; Urschel CW
    Cardiovasc Res; 1972 Jul; 6(4):325-32. PubMed ID: 4625648
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
    Ledingham IM; Marshall RJ; Parratt JR
    Br J Pharmacol; 1973 Mar; 47(3):626P-627P. PubMed ID: 4730845
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nature of the correlation of the adrenergic reactions of the heart and coronary vessels in coronary circulatory disorder].
    Orlova NN
    Farmakol Toksikol; 1987; 50(2):97-9. PubMed ID: 3582645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaxing effect of pharmacologic interventions increasing cAMP in rat heart.
    Vittone L; Grassi A; Chiappe L; Argel M; Cingolani HE
    Am J Physiol; 1981 Apr; 240(4):H441-7. PubMed ID: 6261590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.